These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10869143)

  • 1. Toxicity study of pegaspargase.
    Ettinger LJ; Lerner ED; Manglani MV
    Indian Pediatr; 2000 Jun; 37(6):631-6. PubMed ID: 10869143
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful use of palifermin following severe anaphylaxis to pegaspargase in a pediatric patient with acute lymphoblastic leukemia.
    Kaminski KS; Beach CL; Peden DB; Le U; Roehrs PA
    J Oncol Pharm Pract; 2016 Apr; 22(2):354-6. PubMed ID: 25567519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting success of desensitization after pegaspargase allergy.
    Swanson HD; Panetta JC; Barker PJ; Liu Y; Inaba H; Relling MV; Pui CH; Karol SE
    Blood; 2020 Jan; 135(1):71-75. PubMed ID: 31750901
    [No Abstract]   [Full Text] [Related]  

  • 4. Pegaspargase-induced hypertriglyceridemia in a patient with acute lymphoblastic leukemia.
    Lau KM; Saunders IM; Goodman A
    J Oncol Pharm Pract; 2020 Jan; 26(1):193-199. PubMed ID: 30823860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy observation of polyethylene glycol conjugated asparaginase for induction treatment of children with newly diagnosed acute lymphoblastic leukemia].
    Liu F; Wan Y; Chang L; Guo Y; Yang W; Wang S; Chen X; Liu T; Ruan M; Zhang L; Liu X; Zou Y; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):215-7. PubMed ID: 24824393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegaspargase-induced pancreatitis.
    Alvarez OA; Zimmerman G
    Med Pediatr Oncol; 2000 Mar; 34(3):200-5. PubMed ID: 10696127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegaspargase: A Review in Acute Lymphoblastic Leukaemia.
    Heo YA; Syed YY; Keam SJ
    Drugs; 2019 May; 79(7):767-777. PubMed ID: 31030380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activity of Erwinia-asparaginase after anaphylactic reaction to Peg-asparaginase].
    Viña Romero MM; García Gil S; Nazco Casariego GJ; Merino Alonso J; Gutiérrez Nicolás F
    An Pediatr (Engl Ed); 2019 Mar; 90(3):187-188. PubMed ID: 29705180
    [No Abstract]   [Full Text] [Related]  

  • 9. PEGylated
    Verma A; Chen K; Bender C; Gorney N; Leonard W; Barnette P
    Pediatr Hematol Oncol; 2019 Aug; 36(5):277-286. PubMed ID: 31296092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance.
    Horvat TZ; Pecoraro JJ; Daley RJ; Buie LW; King AC; Rampal RK; Tallman MS; Park JH; Douer D
    Leuk Res; 2016 Nov; 50():17-20. PubMed ID: 27631159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peg-asparaginase for acute lymphoblastic leukemia.
    Rytting M
    Expert Opin Biol Ther; 2010 May; 10(5):833-9. PubMed ID: 20345338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excessive toxicities of pegylated asparaginase in pediatric acute lymphoblastic leukemia patients with high body surface area: A call for action.
    Buhtoiarov IN; Zembillas AS
    Pediatr Blood Cancer; 2021 Mar; 68(3):e28743. PubMed ID: 33009863
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics-based integration of multiple doses of intravenous pegaspargase in a pediatric regimen for adults with newly diagnosed acute lymphoblastic leukemia.
    Douer D; Aldoss I; Lunning MA; Burke PW; Ramezani L; Mark L; Vrona J; Park JH; Tallman MS; Avramis VI; Pullarkat V; Mohrbacher AM
    J Clin Oncol; 2014 Mar; 32(9):905-11. PubMed ID: 24516026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of allergic reactions to intravenous and intramuscular pegaspargase in children with acute lymphoblastic leukemia.
    Petersen WC; Clark D; Senn SL; Cash WT; Gillespie SE; McCracken CE; Keller FG; Lew G
    Pediatr Hematol Oncol; 2014 May; 31(4):311-7. PubMed ID: 24498943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention and management of pegaspargase associated-toxicities (excluding coagulation abnormalities). Recommendations of the French Society of Children and Adolescent Cancers (Leukemia committee)].
    Poirée M; Neumann F; Thomas C; Simon P; Lunven AFR; Plantaz D; Doulet ST; Strullu M
    Bull Cancer; 2022 Nov; 109(11):1125-1131. PubMed ID: 35987855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaphylactic reaction to polyethylene-glycol conjugated-asparaginase: premedication and desensitization may not be sufficient.
    Sahiner UM; Yavuz ST; Gökce M; Buyuktiryaki B; Altan I; Aytac S; Tuncer M; Tuncer A; Sackesen C
    Pediatr Int; 2013 Aug; 55(4):531-3. PubMed ID: 23910807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with apixaban of sinus venous thrombosis due to pegylated asparaginase in a young adult with T cell acute lymphoblastic leukemia: case report and review of management.
    Talamo L; Douvas M; Macik BG; Ornan D
    Ann Hematol; 2017 Apr; 96(4):691-693. PubMed ID: 28132079
    [No Abstract]   [Full Text] [Related]  

  • 18. Levocarnitine and vitamin B complex for the treatment of pegaspargase-induced hepatotoxicity: A case report and review of the literature.
    Blackman A; Boutin A; Shimanovsky A; Baker WJ; Forcello N
    J Oncol Pharm Pract; 2018 Jul; 24(5):393-397. PubMed ID: 28523950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Leucocyte Antigen alleles associated with asparaginase hypersensitivity in childhood Acute Lymphoblastic Leukemia patients treated with Pegylated asparaginase within Dana Farber Cancer Institute treatment protocols.
    Kondyli M; Tremblay DÉ; Rezgui A; Serfaty SA; Gagné V; Ribère M; Laverdière C; Leclerc JM; Tran TH; Sinnett D; Krajinovic M
    Leuk Res; 2021 Oct; 109():106650. PubMed ID: 34198115
    [No Abstract]   [Full Text] [Related]  

  • 20. Allergic Reactions With Intravenous Compared With Intramuscular Pegaspargase in Children With High-risk Acute Lymphoblastic Leukemia: A Population-based Study From the Maritimes, Canada.
    MacDonald T; Kulkarni K; Bernstein M; Fernandez CV
    J Pediatr Hematol Oncol; 2016 Jul; 38(5):341-4. PubMed ID: 26925715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.